Product Information
MIRVASO 0.33% GEL PUMP is a brand product labeled by Galderma Laboratories, L.P., priced at $21.4661 per GM under NDC 00299598035. Its NADAC has been published 390 times since Aug 17, 2016.
FDA first approved this application on Aug 23, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the brimonidine tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/g
Manufacturer
Galderma Laboratories, L.P.NDC
00299598035
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
BRIMONIDINE TARTRATEApproval Type
New Drug (NDA)
FDA Application
NDA204708FDA Approved
8/23/2013
TE Code
AB
On Market Since
8/23/2013
Pharmacological Classes
Price Statistics
The NADAC for MIRVASO 0.33% GEL PUMP has been published 390 times since Aug 17, 2016, and over the history we have for it it has risen 69.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.4661 per GM |
|---|---|
| All-time high | $21.4661 (Aug 19, 2026) |
| All-time low | $12.6563 (Aug 17, 2016) |
| 52-week high | $21.4661 |
| 52-week low | $21.2763 |
| Median price | $16.0120 |
| Average price | $16.6559 |
| Largest weekly change | +15.2% (Jul 23, 2025) |
| Weeks tracked | 390 |
| Tracking since | Aug 17, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MIRVASO 0.33% GEL PUMP?
The current National Average Drug Acquisition Cost (NADAC) for MIRVASO 0.33% GEL PUMP, manufactured by Galderma Laboratories, L.P., is $21.4661 per GM (NDC 00299598035), effective Aug 19, 2026.
How has the price of MIRVASO 0.33% GEL PUMP changed over time?
Over the history we have for it, the NADAC for MIRVASO 0.33% GEL PUMP has risen 69.6%. It has been tracked across 390 weekly CMS publications since Aug 17, 2016.
What are the highest and lowest recorded NADAC prices for MIRVASO 0.33% GEL PUMP?
Since Aug 17, 2016, the NADAC for MIRVASO 0.33% GEL PUMP has ranged from a low of $12.6563 (Aug 17, 2016) to a high of $21.4661 (Aug 19, 2026), with a median of $16.0120 per GM.
Are there cheaper alternatives to MIRVASO 0.33% GEL PUMP?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIRVASO 0.33% GEL, is $16.1504 per GM — about 25% below MIRVASO 0.33% GEL PUMP.
Who manufactures MIRVASO 0.33% GEL PUMP?
MIRVASO 0.33% GEL PUMP (NDC 00299598035) is labeled by Galderma Laboratories, L.P., and CMS classifies it as a brand product.